Task Force 1: preparticipation screening and diagnosis of cardiovascular disease in athletes.
about
Sudden cardiac death athletes: a systematic reviewThe pre-participation examination for leisure time physical activity: general medical and cardiological issuesRunning: the risk of coronary events : Prevalence and prognostic relevance of coronary atherosclerosis in marathon runnersInter Association Task Force recommendations on emergency preparedness and management of sudden cardiac arrest in high school and college athletic programs: a consensus statement.Inter-association Task Force recommendations on emergency preparedness and management of sudden cardiac arrest in high school and college athletic programs: a consensus statementLeft ventricular remodelling index (LVRI) in various pathophysiological conditions: a real-time three-dimensional echocardiographic studyChannelopathies: Brugada syndrome, long QT syndrome, short QT syndrome, and CPVT.Cost-effectiveness of preparticipation screening for prevention of sudden cardiac death in young athletes.Hypertrophic cardiomyopathy: infants, children, and adolescents.Evaluation of cardiac auscultation skills in pediatric residents.Rate of cardiac arrhythmias and silent brain lesions in experienced marathon runners: rationale, design and baseline data of the Berlin Beat of Running study.SELDI-TOF-MS Serum Profiling Reveals Predictors of Cardiac MRI Changes in Marathon RunnersWhat to do with hypertension and a murmur found during a preparticipation physical evaluation?National athletic trainers' association position statement: preventing sudden death in sports.Cardiovascular health, part 1: preparticipation cardiovascular screeningCompeting risks of mortality with marathons: retrospective analysis.Unusual cause of exercise-induced ventricular fibrillation in a well-trained adult endurance athlete: a case report.Cardiomyopathies in childrenSudden cardiac death in athletes: the Lausanne Recommendations.Correlation between the results of three physical fitness tests (endurance, strength, speed) and the output measured during a bicycle ergometer test in a cohort of military servicemen.Interassociation Consensus Statement on Cardiovascular Care of College Student-Athletes.Prevalence of Cardiovascular Disorders Among Iranian Elite AthletesPediatric cardiomyopathies: causes, epidemiology, clinical course, preventive strategies and therapies.Causes of sudden cardiac arrest in young athletes.Hypertension in special populations: athletes.Preparticipation screening and prevention of sudden cardiac death in athletes: implications for primary care.Incidence of sudden cardiac death in athletes: a state-of-the-art review.Interassociation consensus statement on cardiovascular care of college student-athletes.Cost-effectiveness of pre-participation screening of athletes with ECG in Europe and Algeria.Standardised pre-competitive screening of athletes in some European and African countries: the SMILE study.Coronary atherosclerosis burden, but not transient troponin elevation, predicts long-term outcome in recreational marathon runners.Registry on acute cardiovascular events during endurance running races: the prospective RACE Paris registry.Sudden cardiac death in young athletes.Incidence of sudden cardiac death in athletes: a state-of-the-art review.Association of body composition and left ventricular dimensions in elite athletes.The impact of diagnosis: measuring the psychological response to being diagnosed with serious or potentially lethal cardiac disease in young competitive athletes.Prevention of sudden death in adolescent athletes: Incremental diagnostic value and cost-effectiveness of diagnostic tests.The pre-participation screening in young athletes: which protocol do we need exactly?Sport and arrhythmias: summary of an international symposium.Sudden Cardiac Death in Athletes.
P2860
Q21198776-7B343549-A478-4597-88B4-E4A8CDF96E42Q27692617-4886D172-FA3C-4B8E-9AB0-0EBC90CD8779Q28277297-3758B13E-4861-480B-A598-600379DC85E3Q30229502-76AE6FDB-9E09-4A85-8C7A-9026E9761BA1Q30229511-EEFE2ABC-8AA6-4197-BD20-8A17EBD36CBBQ30483594-C63EA898-CD4A-4D39-9F21-D2B1B9F451D2Q33157573-255272C5-C4A3-4FC9-BE47-C74021B7E8C3Q33862846-E188DD01-0CAB-459F-95BF-B5FF469C3794Q34244943-E015CF91-8F35-46FC-BC9C-76C73CC763C5Q34313962-B0619380-84B1-4C9C-8C8A-BD196C32980EQ34400170-D0C7F3E6-95AA-43BA-B340-4006FA737B13Q34417524-4C0EF922-C09F-4717-8E38-B335A6468C2DQ36093033-6E920B36-BB38-4A75-B0BF-EAAAB2A740B7Q36161202-A19124E5-8FB2-4C5F-B434-C0472BC597C5Q36242264-DF5AC0AF-38FA-4BD6-B356-AE000377CB8FQ36294728-75521C5F-1E81-4CCB-A215-FDF06E0C3A5CQ36628585-51FF8970-0A06-4F31-B7E8-E5095905988FQ36660321-F8781462-24A0-4941-8A89-28D4E046F1BEQ36672562-10D57F89-B9FA-4E68-AA17-997E38B65094Q36828970-96C4404E-93B2-47CE-A392-B5A3C7A045A4Q36920885-906BA3CE-BB5D-40A6-AAEE-207A72BCD13AQ37213954-98CE67A6-9A49-431D-B8A7-95E24FBA6863Q37520430-2E9B2A47-B770-4178-BE8D-375BF0E93435Q37777011-5672785B-FD95-401F-A274-6858DF6386EAQ37907333-1C72C35A-3116-44C5-A475-E4D9649856FCQ37983113-340521B4-1A16-483F-955A-9CA5D13CCDC3Q38223080-A5B695B6-5532-4D11-B0BC-DCA57ADEEA86Q38859996-44DEEF0D-8C46-4AA0-BC3C-D70BBF0A56EFQ38882327-BE721FA1-95E1-4D04-A0E5-8B60D2DACC4CQ38882333-8537FD9E-BA04-45E1-A4A1-04C7F3A6C83EQ39311794-F44E62C7-10D9-4CE0-823C-985BA7B70D42Q40160685-C57FD715-DAEE-4ADC-A151-57E65888AFFEQ42173761-EF70DDC2-8773-40C3-BBAA-128EEA7B3731Q43510388-4DC72A5A-BCF7-44DC-9C7E-F0A9BA7D76C9Q43657692-C56D3DF2-0A61-4E59-A044-B20C7F74843FQ46276280-674BFFCC-2F68-4752-BA59-D6FFDACF9CFDQ47339260-7FAEDB19-6595-4EEF-BC1F-A99E8DDF2EB7Q49570291-1C5B18C3-F85A-4CEF-879E-8205DB5E2192Q53227578-4C6B7AD4-355A-44A3-A362-E8CCF16AFC2AQ55190759-231903DD-B71E-49E1-934A-45570B03FDAB
P2860
Task Force 1: preparticipation screening and diagnosis of cardiovascular disease in athletes.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Task Force 1: preparticipation ...... ovascular disease in athletes.
@ast
Task Force 1: preparticipation ...... ovascular disease in athletes.
@en
type
label
Task Force 1: preparticipation ...... ovascular disease in athletes.
@ast
Task Force 1: preparticipation ...... ovascular disease in athletes.
@en
prefLabel
Task Force 1: preparticipation ...... ovascular disease in athletes.
@ast
Task Force 1: preparticipation ...... ovascular disease in athletes.
@en
P2093
P1476
Task Force 1: preparticipation ...... ovascular disease in athletes.
@en
P2093
Barry J Maron
Paul D Thompson
Rick A Nishimura
Thomas P Graham
P304
P356
10.1016/J.JACC.2005.02.007
P407
P577
2005-04-01T00:00:00Z